gvtcx

PHE - Corporate - Newborn Screening for Cystic Fibrosis

UK Health Security Agency Published 4 Nov 2021 Contracts Finder

key details

Value£99,696
Statuscomplete
Category (CPV) 75122000
Deadline27 Aug 2021
Contract start1 Nov 2021
Contract end30 Nov 2022
SME suitableNo
OCIDocds-b5fd17-af33a23f-e5d3-4d89-b9f4-d14e4aabc59f

Award

SupplierValueDateStatus
City, University of London £99,696 1 Nov 2021 active

description

Determining the impact of employing next generation genomic sequencing (NGS) as part of the method of newborn screening for Cystic Fibrosis (CF): a stakeholder engagement project

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
4 Nov 2021 Award (award) · e3b933cf-856b-4d2a-9daf-b7cb57f9696a-482698

more from UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.